athenahealth, Inc. (NASDAQ:ATHN) SVP Jonathan D. Porter sold 300 shares of the company’s stock in a transaction on Tuesday, August 15th. The stock was sold at an average price of $142.88, for a total value of $42,864.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Jonathan D. Porter also recently made the following trade(s):

  • On Friday, July 21st, Jonathan D. Porter sold 422 shares of athenahealth stock. The stock was sold at an average price of $154.00, for a total value of $64,988.00.
  • On Monday, July 17th, Jonathan D. Porter sold 300 shares of athenahealth stock. The stock was sold at an average price of $143.13, for a total value of $42,939.00.
  • On Thursday, June 15th, Jonathan D. Porter sold 300 shares of athenahealth stock. The stock was sold at an average price of $142.27, for a total value of $42,681.00.

Shares of athenahealth, Inc. (ATHN) traded down 2.26% on Thursday, hitting $140.92. The stock had a trading volume of 279,876 shares. athenahealth, Inc. has a 12-month low of $90.11 and a 12-month high of $158.66. The stock has a 50 day moving average price of $142.47 and a 200-day moving average price of $126.04. The company has a market cap of $5.63 billion, a price-to-earnings ratio of 178.83 and a beta of 1.77.

athenahealth (NASDAQ:ATHN) last posted its earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.39 by $0.12. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The business had revenue of $301.10 million during the quarter, compared to the consensus estimate of $298.68 million. During the same period in the previous year, the business earned $0.34 EPS. The business’s quarterly revenue was up 15.0% on a year-over-year basis. On average, equities analysts expect that athenahealth, Inc. will post $1.91 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/08/17/athenahealth-inc-athn-svp-jonathan-d-porter-sells-300-shares.html.

Hedge funds have recently bought and sold shares of the stock. Janus Henderson Group PLC purchased a new stake in athenahealth during the second quarter valued at $713,856,000. BlackRock Inc. increased its stake in athenahealth by 30,642.6% in the first quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider’s stock valued at $180,286,000 after buying an additional 1,594,643 shares during the last quarter. Morgan Stanley increased its stake in athenahealth by 9.7% in the first quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock valued at $508,717,000 after buying an additional 397,837 shares during the last quarter. Elliott Management Corp purchased a new stake in athenahealth during the second quarter valued at $52,706,000. Finally, Clearbridge Investments LLC increased its stake in athenahealth by 61.8% in the first quarter. Clearbridge Investments LLC now owns 908,505 shares of the health services provider’s stock valued at $102,379,000 after buying an additional 347,133 shares during the last quarter.

A number of brokerages recently weighed in on ATHN. Morgan Stanley restated an “equal weight” rating and set a $125.00 price objective (up from $108.00) on shares of athenahealth in a research note on Wednesday, August 2nd. SunTrust Banks, Inc. restated a “buy” rating and set a $170.00 price objective (up from $150.00) on shares of athenahealth in a research note on Wednesday, August 2nd. BidaskClub cut athenahealth from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. Cowen and Company cut athenahealth from an “outperform” rating to a “market perform” rating and upped their price objective for the stock from $127.00 to $133.00 in a research note on Monday, July 31st. Finally, ValuEngine upgraded athenahealth from a “sell” rating to a “hold” rating in a research note on Monday, July 24th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and thirteen have given a buy rating to the company. athenahealth currently has a consensus rating of “Hold” and an average target price of $148.64.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Insider Buying and Selling by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Stock Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related stocks with our FREE daily email newsletter.